相关实验视频

Updated: May 14, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.7K

门诊性瘤的ERAS:改善膀癌治疗 (EMBRACE) 随机对照试验协议

Michael E Rezaee1, Katherine M Mahon1, Bruce J Trock1,2

  • 1The Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.

BMJ open
|June 10, 2024
PubMed
概括

手术后增强恢复 (ERAS) 协议可以改善经过尿道切除膀瘤 (TURBT) 后患者的康复. 本研究将ERAS与 ambulatory TURBT患者的常规护理进行比较,以评估恢复质量.

关键词:
成人瘤学 成人瘤学膀疾病 膀疾病患者报告的结果措施泌尿学 泌尿学是一门学科.泌尿系统瘤 泌尿系统瘤

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Culture of Bladder Cancer Organoids as Precision Medicine Tools08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.6K

相关概念视频

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...